Which funds hold ElevateBio?
From the SEC Form N-PORT filings of US funds, periods ended 2026-05-31 to 2026-07-31
On their latest SEC filings, 20 US funds held ElevateBio, worth $16.9 million in all. Fidelity Contrafund (FCNKX) held the most: $5.9 million, 0.00% of the fund, for the period ended June 30, 2026. The funds that give a share count valued one share at $1.84 to $1.84, $1.84 at the median. The first fund to report it held it in Q1 2021; 20 held it in Q2 2026.
The figures by quarter
| Quarter | Funds | Value held |
|---|---|---|
| Q2 2026 | 20 | $16.9M |
| Q1 2026 | 20 | $17.6M |
| Q4 2025 | 20 | $17.6M |
| Q3 2025 | 20 | $19.2M |
| Q2 2025 | 20 | $18.2M |
| Q1 2025 | 20 | $23.9M |
| Q4 2024 | 20 | $26.8M |
| Q3 2024 | 20 | $29.2M |
| Q2 2024 | 20 | $28.2M |
| Q1 2024 | 20 | $31.9M |
| Q4 2023 | 20 | $28.9M |
| Q3 2023 | 20 | $36.4M |
| Q2 2023 | 20 | $38.6M |
| Q1 2023 | 20 | $28.1M |
| Q4 2022 | 20 | $36.7M |
| Q3 2022 | 20 | $42.1M |
| Q2 2022 | 20 | $42.1M |
| Q1 2022 | 21 | $33.3M |
| Q4 2021 | 21 | $34.2M |
| Q3 2021 | 21 | $38.6M |
| Q2 2021 | 21 | $38.6M |
| Q1 2021 | 11 | $25.0M |
Every fund holding ElevateBio
Largest stake first. The value per share is the fund's value divided by its number of shares, for a fund that gives one; a fund that holds several series of shares can value each one differently.
| Fund | Value | Of the fund | Per share | Period ended |
|---|---|---|---|---|
| Fidelity Contrafund FCNKX, FCNTXSeries C preferred · filing | $5.9M | 0.00% | $1.84 | 2026-06-30 |
| Fidelity Growth Company Fund FDGRX, FGCKXSeries C preferred · filing | $2.8M | 0.00% | $1.84 | 2026-05-31 |
| Fidelity U.S. Equity Central FundSeries C preferred · filing | $1.2M | 0.00% | $1.84 | 2026-06-30 |
| Fidelity Advisor New Insights Fund FINSX, FNIAXSeries C preferred · filing | $1.1M | 0.00% | $1.84 | 2026-06-30 |
| VIP Contrafund PortfolioSeries C preferred · filing | $947,968 | 0.00% | $1.84 | 2026-06-30 |
| Fidelity Contrafund K6 FLCNXSeries C preferred · filing | $895,160 | 0.00% | $1.84 | 2026-06-30 |
| Fidelity Series Growth Company Fund FCGSXSeries C preferred · filing | $611,800 | 0.00% | $1.84 | 2026-05-31 |
| Select Health Care Portfolio FHCLX, FHCNXSeries C preferred · filing | $469,016 | 0.01% | $1.84 | 2026-05-31 |
| Fidelity Growth Company K6 Fund FGKFXSeries C preferred · filing | $455,584 | 0.00% | $1.84 | 2026-05-31 |
| Select Biotechnology Portfolio FBIOXSeries C preferred · filing | $398,544 | 0.01% | $1.84 | 2026-05-31 |
| Select Medical Technology and Devices Portfolio FSMEXSeries C preferred · filing | $395,048 | 0.01% | $1.84 | 2026-05-31 |
| VIP Growth Portfolio QVG2QSeries C preferred · filing | $365,056 | 0.00% | $1.84 | 2026-06-30 |
| Fidelity Series Opportunistic Insights Fund FVWSXSeries C preferred · filing | $357,880 | 0.00% | $1.84 | 2026-06-30 |
| Fidelity Advisor Health Care Fund FACDX, FACTXSeries C preferred · filing | $300,472 | 0.01% | $1.84 | 2026-07-31 |
| Fidelity Capital Appreciation Fund FCAKX, FDCAXSeries C preferred · filing | $283,176 | 0.00% | $1.84 | 2026-07-31 |
| Fidelity Advisor Equity Growth Fund EPGAX, EPGCXSeries C preferred · filing | $204,424 | 0.00% | $1.84 | 2026-05-31 |
| Fidelity Growth Discovery Fund FDSVX, FGDKXSeries C preferred · filing | $139,288 | 0.00% | $1.84 | 2026-06-30 |
| VIP Health Care PortfolioSeries C preferred · filing | $57,408 | 0.01% | $1.84 | 2026-06-30 |
| Fidelity Advisor Series Equity Growth Fund FMFMXSeries C preferred · filing | $48,392 | 0.00% | $1.84 | 2026-05-31 |
| VIP Dynamic Capital Appreciation PortfolioSeries C preferred · filing | $9,752 | 0.00% | $1.84 | 2026-06-30 |
Other private companies US funds hold
- Anthropic 110 funds
- Databricks 98 funds
- Canva 74 funds
- Fanatics 21 funds
- Lightmatter 20 funds
- Tenstorrent 20 funds
- Kardium 20 funds
- Long Wall (ABL Space Systems) 20 funds
Where these figures come from
A holding is a fund's common or preferred share of a company that is not listed: valued with unobservable inputs (fair value level 3) and placed privately (a restricted security, or PP in its title), never a right left from a takeover, an escrow, or a vehicle that holds such shares. A company that funds hold as a listed share in the same data set is public and left out. Rows are joined into a company by its name, its share class and legal form cut off. Each fund values its shares itself, every quarter, so two funds can value one share differently.
Each row is a fund's latest public Form N-PORT. The other private companies US funds hold are on the list of private companies.
Use this data
Every holder, its filing and the history by quarter since 2019 are in elevatebio.json, and every company in the list's file. Free with credit under CC BY 4.0, like the rest of the API.
Cite this page
TickerInside, funds holding ElevateBio, from SEC Form N-PORT (2026q3 data set), https://tickerinside.com/private-companies/elevatebio/
Each value is the fund's own estimate of a share no market quotes, from its latest public SEC Form N-PORT. Measurements of public filings, not investment advice and not a way to buy a share.
